Transgender and gender-nonconforming youth are four times more likely to have a sleep disorder compared to cisgender youth, a Michigan Medicine-led study finds. Researchers also found that those who pursued gender-affirming therapy were half as likely to have any sleep disorder than transgender individuals who did not pursue the therapy, suggesting a possible protective effect.
Transgender and gender diverse (TGD) people assigned male at birth are at increased heart health risk. The delivery route of estrogen medication is known to affect heart health risk in cisgender women. However, research is lacking on how estrogen route affects heart health in the TGD population.
The Endocrine Society rebukes the Florida Board of Medicine’s decision to ban gender-affirming care for transgender and gender-diverse teenagers.
Active testosterone therapy for transgender men may negatively impact IVF outcomes, suggests a mouse study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Transgender individuals are more likely to experience discrimination, isolation, and lack of social support. This, along with negative psychosocial challenges, such as being denied access to gender-neutral restrooms, combined with being a college student, and you have what associate professor of neurology, Shelley Hershner M.D., calls “a perfect storm” that can contribute to sleep disorders and other mental health concerns.
The Endocrine Society objects to the Florida Department of Health’s bulletin on gender-affirming care for transgender and gender-diverse youth. The bulletin contradicts the U.S. Department of Health & Human Services’ resources and the Society’s own evidence-based Clinical Practice Guideline regarding gender-affirming care.
The Endocrine Society applauded the Court of Appeal’s ruling that transgender and gender diverse teenagers are competent to give consent to treatment to delay puberty.
The Endocrine Society and a coalition of LGBTQ+ youth and reproductive health organizations argued in a joint submission to the High Court of England and Wales that transgender teenagers should be able to give informed consent to treatment the same way teenagers with other medical conditions can.
The Endocrine Society—a professional organization of more than 18,000 health care providers and scientists worldwide—praised the American Medical Association’s House of Delegates for passing a resolution opposing efforts to criminalize medical care for transgender youth.
ALBANY, N.Y. (June 11, 2021) — What began as “Gay Pride Day” more than 50 years ago as a commemoration of the Stonewall uprising – demonstrations in reaction to a police raid on a gay bar in New York City…
Register here for panel discussion on June 15, 12:00 p.m. Pacific Time
ROSEMONT, Ill. (June 1, 2021) — Statement from AADA President Kenneth J. Tomecki, MD, FAAD The American Academy of Dermatology Association strongly opposes recent efforts by state legislatures to restrict physicians’ ability to provide care to transgender youths. Legislation such as…
In a landmark case argued by two S.J. Quinney College of Law alums, the Utah Supreme Court ruled on May 6, 2021, that transgender Utahns have a legal right to change the name and gender marker on their birth certificates and other state records.
Medical evidence, not politics, should inform treatment decisions
Transgender youth have higher odds than cisgender youth of being diagnosed with medical conditions that can affect their overall metabolic and cardiovascular health, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
A potentially dangerous side effect of testosterone therapy for transgender men is an increase in red blood cells that can raise the risk of blood clots, heart attack or stroke, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Sen. Paul claimed that allowing biological males to participate in girls’ sports “would completely destroy girls’ athletics.” This has not been proven and some say it misses the point of high school athletic programs.
Besides mislabeling transgender girls as “boys”, Paul provides no true evidence that transgender athletes have negatively effected high school athletic programs.
The United Kingdom’s High Court has granted permission for a coalition of LGBTQ+, youth, reproductive health and medical organizations, including the Endocrine Society, to intervene in an appeal of its decision that minors under age 16 likely could not give informed consent for pubertal suppression.
Highlights from the AJPH March 2021 Issue.
The Endocrine Society and the Pediatric Endocrine Society oppose legislative efforts to block transgender and gender diverse individuals from accessing gender-affirming medical and surgical care, the two medical societies said in a joint policy perspective published in The Journal of Clinical Endocrinology & Metabolism.
People who are transgender and lack access to insurance coverage for gender-affirming hormone therapy are more likely to turn to sources other than a licensed health care provider, a new Michigan Medicine-led study finds.
Gender dysphoria manifests early in childhood and can persist for years before patients undergo counseling and treatment, a Cedars-Sinai study has found. The findings also reveal that untreated gender dysphoria can result in poor quality of life for transgender people, beginning in childhood and lasting throughout adolescence and adulthood.
Gender identity and genetic sex are distinctly variable when it comes to pain tolerance, according to a study published in the Journal of Pain Research.
The Endocrine Society is alarmed by the Administration’s proposed rule to roll back protections for transgender individuals and narrow the scope of the Affordable Care Act (ACA), especially during the COVID-19 pandemic, when everyone needs access to health care. The Society calls on the Administration to maintain access to care protections for all, particularly vulnerable populations.
Two-thirds of transgender teens have depression, and many also have suicidal thoughts and self-injuring behavior, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Researchers surveyed 153 transgender youths receiving gender-affirming care at a specialty clinic, and even in this relatively “out” population, nearly half reported intentionally hiding their gender identity from a health care provider outside the clinic.
The New England Journal of Medicine review by Mount Sinai experts will serve as a major resource and guide for all physicians looking for best care strategies